CONTRAVE

Serial Number 77811077
600

Registration Progress

Application Filed
Aug 24, 2009
Under Examination
Apr 13, 2010
Approved for Publication
Apr 13, 2010
Published for Opposition
Jan 19, 2010
Registered

Trademark Image

CONTRAVE

Basic Information

Serial Number
77811077
Filing Date
August 24, 2009
Published for Opposition
January 19, 2010
Abandonment Date
December 24, 2014
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
600
Status Date
Dec 24, 2014
Classes
016 044

Rights Holder

Orexigen Therapeutics, Inc.

03
Address
3344 North Torrey Pines Court, Suite 200
La Jolla, CA 92037

Ownership History

Orexigen Therapeutics, Inc.

Original Applicant
03
La Jolla, CA

Orexigen Therapeutics, Inc.

Owner at Publication
03
La Jolla, CA

Legal Representation

Attorney
AnneMarie Kaiser

USPTO Deadlines

All Deadlines Cleared

All 8 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

50 events
Date Code Type Description
Dec 24, 2014 ABN0 O ABANDONMENT - INCOMPLETE RESPONSE
Dec 24, 2014 MAB0 O ABANDONMENT NOTICE MAILED - INCOMPLETE RESPONSE
Dec 9, 2014 EXPT T EXPARTE APPEAL TERMINATED
Oct 27, 2014 EXFB T EXPARTE APPEAL DISMISSED - FAILURE TO FILE BRIEF
Jul 18, 2014 CNCF W SU - ACTION CONTINUING FINAL - WRITTEN
Jul 18, 2014 GECD O ACTION DENYING REQ FOR RECON E-MAILED
Jul 18, 2014 GEA1 O NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED
Jul 8, 2014 ALIE A ASSIGNED TO LIE
Jul 8, 2014 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 8, 2014 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 30, 2014 EXAF T EXPARTE APPEAL RECEIVED AT TTAB
Jun 30, 2014 JURT T JURISDICTION RESTORED TO EXAMINING ATTORNEY
Jun 30, 2014 EXPI T EX PARTE APPEAL-INSTITUTED
Jun 30, 2014 ERFR I TEAS REQUEST FOR RECONSIDERATION RECEIVED
Dec 30, 2013 CNFR W SU - FINAL REFUSAL - WRITTEN
Dec 30, 2013 GNFR O FINAL REFUSAL E-MAILED
Dec 30, 2013 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED
Dec 4, 2013 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 3, 2013 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 3, 2013 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 3, 2013 CNRT W SU - NON-FINAL ACTION - WRITTEN
Jun 3, 2013 GNRT O NON-FINAL ACTION E-MAILED
Jun 3, 2013 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 7, 2013 SUPC I STATEMENT OF USE PROCESSING COMPLETE
May 3, 2013 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Apr 12, 2013 EISU I TEAS STATEMENT OF USE RECEIVED
Apr 12, 2013 IUAF S USE AMENDMENT FILED
Sep 29, 2012 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 28, 2012 EX5G S SOU EXTENSION 5 GRANTED
Sep 26, 2012 EEXT I SOU TEAS EXTENSION RECEIVED
Sep 26, 2012 EXT5 S SOU EXTENSION 5 FILED
Apr 10, 2012 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 9, 2012 EX4G S SOU EXTENSION 4 GRANTED
Mar 29, 2012 EEXT I SOU TEAS EXTENSION RECEIVED
Mar 29, 2012 EXT4 S SOU EXTENSION 4 FILED
Oct 18, 2011 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 17, 2011 EX3G S SOU EXTENSION 3 GRANTED
Oct 12, 2011 EEXT I SOU TEAS EXTENSION RECEIVED
Oct 12, 2011 EXT3 S SOU EXTENSION 3 FILED
Apr 15, 2011 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 14, 2011 EX2G S SOU EXTENSION 2 GRANTED
Apr 12, 2011 EEXT I SOU TEAS EXTENSION RECEIVED
Apr 12, 2011 EXT2 S SOU EXTENSION 2 FILED
Sep 1, 2010 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 31, 2010 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Aug 31, 2010 EX1G S SOU EXTENSION 1 GRANTED
Aug 9, 2010 EEXT I SOU TEAS EXTENSION RECEIVED
Aug 9, 2010 EXT1 S SOU EXTENSION 1 FILED
Apr 13, 2010 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT
Jan 19, 2010 PUBO A PUBLISHED FOR OPPOSITION

Detailed Classifications

Class 016
Printed materials, namely, bulletins on the topic of weight management and treatment of obesity
First Use Anywhere: 20130200
First Use in Commerce: 20130200
Class 044
Medical information services, namely, providing health information in the field of weight management and the treatment of obesity
First Use Anywhere: 20130200
First Use in Commerce: 20130200

Classification

International Classes
016 044